AB4AD logo

AB4AD
AB4AD (Antibodies for Alzheimer's Disease)

0
Mkt Cap
$90,132.00
24H Volume
$726.48
FDV
$90,132.00
Circ Supply
1M
Total Supply
1M
AB4AD Fundamentals
Max Supply
1M
7D High
$0.0901
7D Low
$0.0881
24H High
$0.00
24H Low
$0.00
All-Time High
$0.3762
All-Time Low
$0.0624
AB4AD Prices
AB4AD / USD
$0.0901
AB4AD / EUR
€0.0777
AB4AD / GBP
£0.0681
AB4AD / CAD
CA$0.1265
AB4AD / AUD
A$0.138
AB4AD / INR
₹8.05
AB4AD / NGN
NGN 130.20
AB4AD / NZD
NZ$0.1575
AB4AD / PHP
₱5.30
AB4AD / SGD
SGD 0.1169
AB4AD / ZAR
ZAR 1.55
Loading...
Loading...
News
all
press releases

Sentiment

Indicates whether most users posting on a symbol’s stream over the last 24 hours are fearful or greedy.
0
25
50
75
100
Extreme
Fear
Neutral
Greed
Extreme
Fear
Greed
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Message Volume

Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Participation Ratio

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

AboutAb4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).
Details
Links
Source
Categories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
November 28, 2025
$90,140.83
$726.48
$0.0901
November 27, 2025
$90,132.35
$726.48
$0.0901
November 27, 2025
$90,140.83
$726.48
$0.0901
November 21, 2025
$86,215.28
$286.46
$0.0862
November 20, 2025
$86,672.15
$287.97
$0.0867
November 19, 2025
$86,212.60
$286.45
$0.0862
November 15, 2025
$100,500.33
$497.67
$0.1005
November 14, 2025
$100,500.69
$497.67
$0.1005
November 13, 2025
$107,100.88
$1,083.03
$0.1071
November 12, 2025
$103,120.13
$195.37
$0.1023

Latest AB4AD News

No AB4AD.X news at the moment.

Advertisement|Remove ads.